Business Description
Curis is a US-based biotechnology company focused on developing new medicines to treat various forms of cancer. The company has several drugs in development, including treatments targeting blood cancers and lymphoma, as well as compounds designed to help the immune system fight tumors. Curis works alongside major partners such as Genentech, Roche, and Aurigene to advance these programs, and already has one approved cancer treatment on the market. Founded in 2000 and based in Lexington, Massachusetts, the company continues to build its portfolio of cancer therapies through both internal research and collaborative efforts.
